Latest Leadership Changes News

TrivarX appoints Dr Danielle Meyrick as CEO to spearhead clinical trials and commercialisation of its novel stable isotope MRI brain cancer imaging platform, with Phase 1 studies on track for completion this year.

Alicanto Minerals has kicked off a 50,000-metre drilling campaign to expand the 915,000oz Mt Henry gold resource, backed by a fresh $18.1 million non-dilutive funding package and key leadership changes.

Xpedra Resources has reported promising initial drilling results at its Springfield Gold Deposit and secured a high-grade historical goldfield at Neeld, backed by a $3.2 million placement and new leadership.

Belararox has ramped up drilling at its TMT Project in Argentina, unveiling a significant high-grade silver zone at Toro Central and expanding its landholding with the El Faro acquisition. Meanwhile, exploration in Botswana gears up with a major airborne electromagnetic survey, and the company contemplates divesting its Australian Belara Project to sharpen focus on core assets.

EVE Health Group has begun commercial sales of Libbo, an oral dissolving film for erectile dysfunction, supported by a new digital men’s health platform. The company also expanded its pharmaceutical pipeline and secured $1.3 million in fresh capital to fund ongoing development and commercialization.

Janus Electric has begun generating export revenue in the US while expanding its electric truck fleet to 28 vehicles and significantly improving its cash position through a $1.4 million R&D tax refund and a $2.75 million finance facility.

Xamble Group stabilised revenue at A$1.64 million in Q1 2026 while narrowing its group EBITDA loss slightly despite ramped-up technology spending. The company completed its acquisition of YouthsToday, tripling its influencer base and locking in three commercial contracts worth A$1.17 million.

Horizon Gold has confirmed new high-grade gold shoots at its Kingfisher prospect, underpinning resource growth potential, while progressing a major $30 million capital raise and leadership transition.

Proteomics International is pivoting from research to disciplined commercial execution of its proteomics-based diagnostic tests, focusing on distributor partnerships and reimbursement pathways in Australia and the US.

Vanadium Resources (ASX: VR8) has signed a non-binding offtake term sheet with U.S. Vanadium for 100% of vanadium slag from its Steelpoortdrift V-Iron Plant, while appointing Rand Merchant Bank to secure project financing.

EVE Health Group has appointed Ben Rohr as CEO, shifting Damian Wood to focus on regulatory and clinical affairs, aiming to sharpen commercial execution amid ongoing product rollouts.

Platina Resources has launched an extensive 2026 drilling campaign across its Laverton gold portfolio, while advancing key acquisitions to nearly double its landholding and navigating leadership changes.